COVID-19 & CancerFreeGuest Editorial COVID-19 and community cancer careA Panorama of a Catastrophe May 08, 2020Vol.46 No.19By Debra Patt and Michael Kolodziej
COVID-19 & CancerFreeGuest Editorial Cancer doesn’t wait—we are treating cancer patients now May 01, 2020Vol.46 No.18By Richard Bold and Timothy Donahue
COVID-19 & CancerFreeGuest Editorial The pandemic of COVID-19 and its effect on clinical trials in the communityHow do we move forward? May 01, 2020Vol.46 No.18By James N. Atkins
COVID-19 & CancerFreeGuest Editorial Under the onslaughts of COVID-19, Montefiore deployed a PPE strategy for patients—PREVENT/PROTECT/ENABLE May 01, 2020Vol.46 No.18By Balazs Halmos, Roman Perez-Soler, Stuart Packer, Mary G. LaRocca, Bruce Rapkin, Shalom Kalnicki and Joseph Sparano
COVID-19 & CancerFreeGuest Editorial COVID-Lung Cancer Consortium:An example of how the lung cancer community came together in a challenging time April 24, 2020Vol.46 No.17By Fred R. Hirsch, Paul A. Bunn Jr and John D. Minna
COVID-19 & CancerFreeGuest Editorial When disparities widen: COVID-19 in minority patients with cancer April 24, 2020Vol.46 No.17By Coral Olazagasti and Narjust Florez
COVID-19 & CancerFreeGuest Editorial Cancer care continues during COVID-19 pandemic—with new tools and old challenges April 17, 2020Vol.46 No.16By Ted Okon
COVID-19 & CancerFreeGuest Editorial Amid COVID-19 pandemic, cancer community responds to fill data gap April 17, 2020Vol.46 No.16By Richard L. Schilsky
COVID-19 & CancerFreeGuest Editorial Chernobyl doctor’s view of COVID-19: Trump threatens 267 years of progress in biomedical research April 10, 2020Vol.46 No.15By Robert Peter Gale
COVID-19 & CancerFreeGuest Editorial NCTN group chairs: Cancer trials take backseat to clinical care amid COVID-19 pandemic April 10, 2020Vol.46 No.15By Charles D. Blanke, Douglas S. Hawkins, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Walter J. Curran, Norman Wolmark, Robert S. Mannel and Janet Dancey
